Cited by 131Thyroid Disorders and TreatmentsBone Metabolism and DiseasesGrowth Hormone and Insulin-like Growth Factors

A Thyrotoxic Skeletal Phenotype of Advanced Bone Formation in Mice with Resistance to Thyroid Hormone

Open access
O’Shea, Patrick J., Harvey, Clare B., Suzuki, Hideyo, Kaneshige, Masahiro, Kaneshige, Kumiko, Cheng, Sheue-Yann, Williams, Graham R.·2003·Molecular Endocrinology

Abstract

Thyroid hormone (T3) regulates bone turnover and mineralization in adults and is essential for skeletal development during childhood. Hyperthyroidism is an established risk factor for osteoporosis. Nevertheless, T3 actions in bone remain poorly understood. Patients with resistance to thyroid hormone, due to mutations of the T3-receptor beta (TRbeta) gene, display variable phenotypic abnormalities, particularly in the skeleton. To investigate the actions of T3 during bone development, we characterized the skeleton in TRbetaPV mutant mice. TRbetaPV mice harbor a targeted resistance to thyroid hormone mutation in TRbeta and recapitulate the human condition. A severe phenotype, which includes shortened body length, was evident in homozygous TRbetaPV/PV animals. Accelerated growth in utero was associated with advanced endochondral and intramembranous ossification. Advanced bone formation resulted in postnatal growth retardation, premature quiescence of the growth plates, and shortened bone length, together with increased bone mineralization and craniosynostosis. In situ hybridization demonstrated increased expression of fibroblast growth factor receptor-1, a T3-regulated gene in bone, in TRbetaPV/PV perichondrium, growth plate chondrocytes, and osteoblasts. Thus, the skeleton in TRbetaPV/PV mice is thyrotoxic and displays phenotypic features typical of juvenile hyperthyroidism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2002-0296

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The skeletal phenotype in mouse models of RTHβ is due to increased T3 action in cartilage and bone.

    “Nevertheless, analysis of the skeletal consequences of mutations of Thrb in mouse models of RTHβ is consistent with a skeletal phenotype of accelerated bone development in juveniles and increased bone turnover with osteoporosis in adults that is due to increased T3 action in cartilage and bone [1, 83, 89–91].”

    From Thyroid diseases and bone health (2018) · cites this paper as [91]

  • Analysis of the skeletal consequences of mutations of Thrb in mouse models of RTHβ is consistent with a skeletal phenotype of accelerated bone development in juveniles and increased bone turnover with osteoporosis in adults.

    “Nevertheless, analysis of the skeletal consequences of mutations of Thrb in mouse models of RTHβ is consistent with a skeletal phenotype of accelerated bone development in juveniles and increased bone turnover with osteoporosis in adults that is due to increased T3 action in cartilage and bone [1, 83, 89–91].”

    From Thyroid diseases and bone health (2018) · cites this paper as [91]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
O’Shea, P. J., Harvey, C. B., Suzuki, H., Kaneshige, M., Kaneshige, K., Cheng, S.-Y., & Williams, G. R.
Affiliations
  • Molecular Endocrinology Group (P.J.O., C.B.H., G.R.W.), Division of Medicine and Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom
  • Hammersmith Hospital (GB)
  • National Institutes of Health (US)
Corresponding author
Williams, Graham R.
Venue
Molecular Endocrinology
Published
2003-07-01
Volume
17
Issue
7
Pages
1410-1424
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2153204201
Cited by
131
References
2
Citations by year
2026: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2020: 4 · 2019: 5 · 2018: 9 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 12
FWCI
6.06
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Endocrinology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
thyroid hormone resistance, thyroid hormone receptor beta, endochondral ossification, intramembranous ossification, craniosynostosis, FGFR1, bone mineralization, skeletal development
MeSH terms
Animals, Animals, Newborn, Body Height, Bone and Bones, Bone Development, Craniosynostoses, Female, Growth Plate, Hyperthyroidism, Male, Mice, Mutant Strains, Receptors, Thyroid Hormone, Thyroxine, Bone Density, Receptors, Fibroblast Growth Factor, Limb Deformities, Congenital, Thyroid Hormone Resistance Syndrome, Gene Expression Regulation, Developmental, Receptor Protein-Tyrosine Kinases, Thyroid Hormone Receptors beta, Mice, Receptor, Fibroblast Growth Factor, Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review